Financhill
Back

Ionis Pharmaceuticals Quote, Financials, Valuation and Earnings

Ionis Pharmaceuticals Price Quote

$45.81
-0.72 (-1.55%)
(Updated: February 29, 2024 at 1:45 PM ET)

Ionis Pharmaceuticals Key Stats

Sell
47
Ionis Pharmaceuticals (IONS) is a Sell

Day range:
$46.48 - $47.66
52-week range:
$32.69 - $54.44
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.46
P/B ratio:
17.54%

Volume:
967.9K
Avg. volume:
1.3M
1-year change:
29.61%
Market cap:
$6.8B
Revenue:
$787.6M
EPS:
$-2.56

How Much Does Ionis Pharmaceuticals Make?

Is Ionis Pharmaceuticals Growing As A Company?

  • What Is Ionis Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 1.14%
  • What Is Ionis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Ionis Pharmaceuticals Stock Price Performance

What Is Ionis Pharmaceuticals 52-Week High & Low?

Ionis Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ionis Pharmaceuticals?

Is Ionis Pharmaceuticals Cash Flow Positive?

  • What Is IONS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$307.5M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $644.1M
  • What Is Ionis Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$214.1M

Ionis Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    IONS return on invested capital is -21.7%
  • What Is Ionis Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -12.79%
  • What Is IONS Return On Equity?
    ROE is a measure of profitability and is -83.63%

Ionis Pharmaceuticals Earnings Date & Stock Price

Ionis Pharmaceuticals Competitors

Ionis Pharmaceuticals Dividend Yield

Data Unavailable

Ionis Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 115.8%
Revenue: 113.65% 90.17%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 7
Sell Recommendations: 1
Price Target: 56.40
Upside from Last Price: 21.21%

Major Shareholders

  • How many IONS shares are owned by institutional investors?
    256.2M IONS shares are owned by institutional investors
  • How many IONS shares are owned by insiders?
    1.3M IONS shares are owned by insiders